Max Robotics — Global Service Robot Directory + US Certification

About

Antoni Vilaseca is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for prostate and kidney cancers. His major contributions include refining risk stratification for biochemical recurrence after robotic-assisted radical prostatectomy, demonstrating that not all positive surgical margins carry equal prognostic weight—a finding with direct implications for postoperative management. In renal surgery, Vilaseca has systematically evaluated nephrometry scoring systems to predict perioperative outcomes following robotic partial nephrectomy, helping surgeons tailor approaches to tumor complexity. His research also addresses the morbidity of salvage radical prostatectomy, showing that minimally invasive approaches offer limited benefit in this high-risk setting, and he has explored innovative uses of intravenous indocyanine green to assess ureteral vascularity during robot-assisted cystectomy. With over 47 citations across his most-cited works, Vilaseca’s impact is evident in his ability to translate surgical nuance into actionable clinical insights. His pioneering work on robotic kidney transplantation with transvaginal graft insertion further underscores his commitment to pushing the boundaries of urologic surgery.